The April personal consumption expenditures report will give investors another look at the inflation picture.
Category: Uncategorized
Moderna and this solar name are among the most overbought stocks after a record-setting week
Certain stocks this week became overbought, based on their 14-day relative strength index, or RSI.
Here’s where BlackRock’s bond guru Rick Rieder sees opportunity right now
In this market, investors can grab some great yields and not have to take any big risks to get them, said BlackRock global fixed income CIO Rick Rieder.
These are Wall Street’s favorite travel and leisure stocks heading into the unofficial start of summer
Hotels, airlines and others could gain in anticipation of profits from a busy summer travel and leisure season.
Here are JPMorgan’s top clean energy picks for the rest of 2024
JPMorgan’s top alt energy picks for the rest of the year are two smaller, lesser-known stocks.
These AI plays are still cheap even after this year’s incredible Nvidia-driven bull run
CNBC Pro screened for artificial intelligence plays that are considered “cheap.”
Nvidia’s stock split makes it a Dow contender — but not a shoo-in
An index committee looks for a stock with “an excellent reputation” and sustained growth that is “of interest to a large number of investors.”
This DoubleLine bond fund is beating the market. Here’s what it’s buying
DoubleLine’s Jeffrey Sherman spoke to CNBC about the risks to the economy and what part of the bond market makes the most sense for investors.
Morgan Stanley tells investors to avoid hedge funds’ overcrowded trades
Owning hedge funds’ most crowded trades could be risky in the event of a herd-like stampede from systematic traders, Morgan Stanley said.
This up-and-coming cancer treatment could be a $25 billion market opportunity — it’s already a hotbed for M&A
Targeted radiopharmaceuticals, which deliver radiation directly into tumors, has caught the eye of big pharma.